title: Composite endpoints and the distortion of risk-benefit analysis.
authors.affiliation: 196 Rotherhithe Street, London, SE16 7RB, UK.
authors.forename: John B
authors.initials: JB
authors.lastname: Warren
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000401:mortality; D002491:Central Nervous System Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D011307:Drug Prescriptions; D023381:Endpoint Determination / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000401:mortality; D018570:Risk Assessment / Q000379:methods
chemical_list: D002317:Cardiovascular Agents; D002491:Central Nervous System Agents